Autologous stem-cell transplantation after second-line brentuximab vedotin in relapsed or refractory Hodgkin lymphoma.
Ann Oncol
; 29(3): 724-730, 2018 03 01.
Article
in En
| MEDLINE
| ID: mdl-29272364
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Hodgkin Disease
/
Combined Modality Therapy
/
Immunoconjugates
/
Hematopoietic Stem Cell Transplantation
/
Antineoplastic Agents, Immunological
Type of study:
Clinical_trials
Limits:
Adolescent
/
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Ann Oncol
Journal subject:
NEOPLASIAS
Year:
2018
Document type:
Article
Affiliation country:
United States
Country of publication:
United kingdom